Australia (AU)

A study protocol for a systematic review and meta-analysis on macroscopic body movements as a marker for acute stress (2026) Kurz M, Ringgold V, Abel L, Burkhardt F, Richer R, Schindler-Gmelch L, Turner AI, et al. Journal article Intestinal Sclerostin Deficiency Links Gut Dysbiosis to Altered Serotonin Homeostasis in Axial Spondyloarthritis (2026) Mauro D, Bergot AS, Guggino G, Salzillo A, Forte G, Ciancio A, Rizzo A, et al. Journal article PLAY+ (Play, Land, Animals, You and +) framework: The role of active outdoor play in advancing One Health (2026) Lee EY, Kim YB, Cheng J, Carbone M, Abu-Omar K, Bisung E, Ding D, et al. Journal article, Review article In-situ nanomechanical responses of zirconia-containing lithium silicate glass-ceramics (2026) Juri AZ, Belli R, De Souza G, Lohbauer U, Nakanishi Y, Yin L Journal article Impact of centrally acting sympatholytic agents on the blood pressure response to renal denervation (2026) Nolde JM, Kiuchi MG, Carnagarin R, Ward NC, Wanten M, Böhm M, Mahfoud F, et al. Journal article Cracking the crust: Rifting and lateral magma transport at the early Holocene Sveinar-Randarhólar Fissure, NE Iceland (2026) Abersteiner A, Beier C, Halldórsson SA, Marshall EW, Ranta E, Sigurgeirsson M, Whitehouse M, Jeon H Journal article Advancing CNS tumor diagnostics with expanded DNA methylation-based classification (2026) Sill M, Schrimpf D, Patel A, Sturm D, Jäger N, Sievers P, Schweizer L, et al. Journal article WHY THE POLYVAGAL THEORY IS UNTENABLE An international expert evaluation of the polyvagal theory and commentary upon Porges, S.W. (2025). Polyvagal theory: current status, clinical applications, and future directions. Clin. Neuropsychiatry, 22(3), 169-184. (2026) Grossman P, Ackland GL, Allen AM, Berntson GG, Booth LC, Burghardt GM, Buron J, et al. Journal article Tipping the balance: the PD1-axis as a modulator in chronic inflammatory demyelinating polyneuropathy (2026) Sgodzai M, Klöster K, Karakaya H, Didehvar P, Horstkemper L, Rilke N, Demir S, et al. Journal article Real-world 5-year outcomes with durvalumab after chemoradiotherapy in unresectable stage III NSCLC (2026) Girard N, Bar J, Baas P, Chouaid C, Christoph DC, Field JK, Fietkau R, et al. Journal article